These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37960216)

  • 1. Regular Exercise Improved Fatigue and Musculoskeletal Pain in Young Adult Psoriatic Patients without Psoriatic Arthritis.
    Diaz AJ; Rosety MA; Armario JC; Bandez MJ; Garcia-Gomez N; Sanchez-Sanchez E; Diaz J; Castejon-Riber C; Bernardi M; Rosety-Rodriguez M M; Ordonez FJ; Rosety I
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study.
    Gok K; Nas K; Tekeoglu I; Sunar I; Keskin Y; Kilic E; Sargin B; Acer Kasman S; Alkan H; Sahin N; Cengiz G; Cuzdan N; Albayrak Gezer İ; Keskin D; Mulkoglu C; Resorlu H; Bal A; Duruoz MT; Kucukakkas O; Yurdakul OV; Alkan Melikoglu M; Aydin Y; Ayhan FF; Bodur H; Calis M; Capkin E; Devrimsel G; Ecesoy H; Hizmetli S; Kamanli A; Kutluk O; Sen N; Sendur OF; Tolu S; Toprak M; Tuncer T
    Rheumatol Int; 2022 Apr; 42(4):659-668. PubMed ID: 34453579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial.
    Gladman DD; Mease PJ; Cifaldi MA; Perdok RJ; Sasso E; Medich J
    Ann Rheum Dis; 2007 Feb; 66(2):163-8. PubMed ID: 17046964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with SDZ-ADL, an Adalimumab Biosimilar, in Patients with Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis: Results of Patient-Reported Outcome Measures from Two Phase III Studies (ADMYRA and ADACCESS).
    Blauvelt A; Leonardi CL; Gaylis N; Jauch-Lembach J; Balfour A; Lemke L; Hachaichi S; Brueckmann I; Festini T; Wiland P
    BioDrugs; 2021 Mar; 35(2):229-238. PubMed ID: 33651341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Database.
    Merola JF; Patil D; Egana A; Steffens A; Webb NS; Gottlieb AB
    Dermatol Ther (Heidelb); 2023 Nov; 13(11):2635-2648. PubMed ID: 37726542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported Health-related Quality of Life with apremilast for psoriatic arthritis: a phase II, randomized, controlled study.
    Strand V; Schett G; Hu C; Stevens RM
    J Rheumatol; 2013 Jul; 40(7):1158-65. PubMed ID: 23588944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Non-pharmacological Treatment on Pain, Morning Stiffness, Fatigue, and Physical Function in Patients with Psoriatic Arthritis.
    Špoljarić Carević S; Car J; Čota S; Delimar V; Perić P; Laktašić-Žerjavić N
    Acta Dermatovenerol Croat; 2020 Dec; 28(3):148-153. PubMed ID: 33422168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The musculoskeletal impairment negatively impacts the quality of life of children and adolescents with psoriasis.
    Meneghetti TC; Padilha TMH; Azevedo VF; Cat MNL; Sarolli BMS; de Carvalho VO
    Adv Rheumatol; 2020 Jun; 60(1):33. PubMed ID: 32552795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability of low to moderate biomechanical stress during leisure sport activity in patients with psoriasis and psoriatic arthritis.
    Fagni F; Mutlu MY; Temiz SA; Minopoulou I; Krieter M; Schett G; Kleyer A; Simon D; Hueber AJ
    RMD Open; 2023 Dec; 9(4):. PubMed ID: 38053458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study.
    Sunar I; Ataman S; Nas K; Kilic E; Sargin B; Kasman SA; Alkan H; Sahin N; Cengiz G; Cuzdan N; Gezer IA; Keskin D; Mülkoğlu C; Resorlu H; Bal A; Duruöz MT; Küçükakkaş O; Yurdakul OV; Melikoglu MA; Aydın Y; Ayhan FF; Bodur H; Calis M; Capkın E; Devrimsel G; Gok K; Hizmetli S; Kamanlı A; Keskin Y; Kocabas H; Kutluk O; Şen N; Şendur OF; Tekeoğlu I; Tolu S; Toprak M; Tuncer T
    Rheumatol Int; 2020 Feb; 40(2):283-294. PubMed ID: 31773391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE.
    Mease PJ; Asahina A; Gladman DD; Tanaka Y; Tillett W; Ink B; Assudani D; de la Loge C; Coarse J; Eells J; Gossec L
    Rheumatology (Oxford); 2023 Feb; 62(2):617-628. PubMed ID: 35789257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Development of Psoriatic Arthritis in Patients With Psoriasis Is Preceded by a Period of Nonspecific Musculoskeletal Symptoms: A Prospective Cohort Study.
    Eder L; Polachek A; Rosen CF; Chandran V; Cook R; Gladman DD
    Arthritis Rheumatol; 2017 Mar; 69(3):622-629. PubMed ID: 27792862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global visual analog scales.
    Kwok T; Pope JE
    J Rheumatol; 2010 May; 37(5):1024-8. PubMed ID: 20231193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients With Psoriatic Arthritis: 24-Week Results of the GO-VIBRANT Trial.
    Husni ME; Kavanaugh A; Chan EKH; Peterson S; Li N; Hsia EC; Kim L; Lo KH; Harrison DD; Han C
    Value Health; 2020 Oct; 23(10):1286-1291. PubMed ID: 33032771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatigue in psoriatic arthritis: Is it related to disease activity?
    Lai TL; Au CK; Chung HY; Leung MC; Ng WL; Lau CS
    Int J Rheum Dis; 2021 Mar; 24(3):418-425. PubMed ID: 33506651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in oxylipin profile in psoriasis versus psoriatic arthritis.
    Coras R; Kavanaugh A; Kluzniak A; Holt D; Weilgosz A; Aaron A; Quehenberger O; Ritchlin C; Guma M
    Arthritis Res Ther; 2021 Jul; 23(1):200. PubMed ID: 34303373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens.
    Gniadecki R; Robertson D; Molta CT; Freundlich B; Pedersen R; Li W; Boggs R; Zbrozek AS
    J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1436-43. PubMed ID: 22035157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).
    Duvetorp A; Østergaard M; Skov L; Seifert O; Tveit KS; Danielsen K; Iversen L
    Arch Dermatol Res; 2019 Jul; 311(5):351-360. PubMed ID: 30868221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of an Interdisciplinary Dermatological-Rheumatological Consultation on the Outcome of Patients with Psoriasis with Musculoskeletal Pain: A Prospective, Single-Center Cohort Study.
    von Ahnen JA; Gross G; Lull C; Blauth M; Kraemer B; Olsavszky V; Leipe J; Schmieder A
    Adv Ther; 2023 Dec; 40(12):5243-5253. PubMed ID: 37768507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2.
    Ostor AJK; Soliman AM; Papp KA; Padilla B; Wang Z; Eldred A; de Vlam K; Kivitz A
    RMD Open; 2022 Jun; 8(2):. PubMed ID: 35701011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.